Role of Surface Negative Charge in Platelet Function Related to the Hyperreactive State in Estrogen-Treated Prostatic Carcinoma

Summary

The relationship between platelet surface negative charge and hyperfunction was examined by determining electrophoretic mobility (EPM), aggregability, and sialic acid of platelets in prostatic cancer, prostatic cancer with estrogen, prostatic cancer with estrogen and aspirin, prostatic hypertrophy, and healthy aged males. Estrogen treated prostatic cancer patients had significantly higher platelet EPM. A good linear correlation was found between sialic acid and EPM (r = 0.97, p <0.001). EPM was negatively correlated with primary aggregations by adrenaline and ADP but not with secondary or maximum aggregations, suggesting increased surface negative charge may inhibit primary aggregation. Estrogen and platelet population changes influenced surface negative charge. Neuraminidase removal of platelet surface sialic acid resulted in dose-dependent decreases of EPM which paralleled decreases in sialic acid. Aspirin treated patients and platelets incubated with aspirin in vitro both showed increased platelet EPM. These results suggest that platelet surface negative charge may directly affect platelet function.

Key words

Platelet electrophoretic mobility (EPM) - Surface negative charge - Estrogen - Prostatic cancer - Sialic acid

• References

• 1 Davis JW, Yue KTN, Phillips PhE. The effects of neuraminidase on platelet aggregation induced by ADP, norepinephrine, collagen, or serotonin. Thrombos Diathes Haemorrh 1972; 28: 221-227
• 2 Mester L, Szabados L, Born GVR, Micahl F. Changes in aggregation of platelets enriched in sialic acid. Nature 1972; 236: 213-214
• 3 Greenberg J, Packham MA, Cazenave JP, Reimers HJ, Mustard JF. Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab Invest 1975; 32: 476-484
• 4 Seaman GVF. Surface potential and platelet aggregation. In: Brinkhous KM, Wright IS, Soulier JP, Roberts HR, Hinnom S. (eds). Platelets. Their Role in Haemostasis and Thrombosis. 53-68 Schattauer-Verlag; Stuttgart: 1967
• 5 Yamazaki H, Tsukui R, Motomiya T, Jung SM, Sonoda M, Watanabe C, Ogino M, Miyagawa N. The increase of the electrophoretic mobility of platelets after laparotomy. Thromb Haemostas 1980; 44: 43-45
• 6 Blackard CE, Doe R, Mellinger GT, Byar DP. Incidence of cardiovascular disease and death in patients receiving diethylstilbesterol for carcinoma of the prostate. Cancer 1970; 246: 249-256
• 7 Byar DP. Treatment of prostatic cancer. Studies by the Veterans Administration Cooperative Urological Research Group. Bull NY Acad Sci 1972; 48: 751-766
• 8 Eisen M, Napp HE, Vock R. Thrombozyten-Aggregationshemmung bei Oestrogen-behandelten Prostata-Karzinom-Patienten. Urologie [Ausg A] 1975; 14: 132-136
• 9 Eisen M, Napp HE, Vock R. Inhibition of platelet aggregation caused by estrogen treatment in patients with carcinoma of the prostate. J Urol 1975; 114: 93-107
• 10 Phillips DR. Effect of trypsin on the exposed polypeptides and glycoproteins of human platelet membranes. Biochemistry 1972; 11: 4582-4588
• 11 Yamazaki H, Takahashi T, Sano T. Hyperaggregability of platelets in thromboembolic disorders. Thrombos Diathes Haemorrh 1975; 34: 94-105
• 12 Zeiller K, Hannig K. Free flow electrophoretic separation of lymphocytes. Evidence for specific organ distributions of lymphoid cells. Hoppe Seyler’s Z Physiol Chem 1971; 352: 1162-1167
• 13 Warren L. The thiobarbituric add analysis of sialic adds. J Biol Chem 1959; 234: 1971-1975
• 14 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-276
• 15 Kirby EP, Mills DCB. The interaction of bovine factor VIII with human platelets. J Clin Invest 1975; 56: 491-502
• 16 Hayano S, Tanaka A. Streptococcal sialidase: 1. Isolation and properties of sialidase produced by group K streptococcus. J Bacteriol 1967; 93: 1753-1757
• 17 Yamazaki H, Motomiya T, Kikutani N, Sakakibara C, Watanabe S, Numata M, Noguchi K. Platelet aggregation during menstrual cycle and pregnancy. Thromb Res 1979; 14: 333-340
• 18 Vessey MP, Doll R. Investigation of relationship between use of oral contraceptives and thromboembolic disease. Br Med J 1968; 2: 199-205
• 19 Royal College of General Practitioners Oral Contraceptive Study. Mortality among oral contraceptive users. Lancet 1977; 2: 727-731
• 20 Vessey MP, McPherson K, Johnson B. Mortality among women partidpating in the Oxford/family planning assodation contraceptive study. Lancet 1977; 2: 731-733
• 21 Coller BS, Franza Jr BR, Gralnick HR. The pH dependence of quantitative ristocetin-induced aggregation: theoretical and practical implications - A new device for maintenance of platelet rich plasma pH. Blood 1976; 47: 841-854
• 22 Massini P. The role of calcium in the stimulation of platelets. In: Mills DCB, Pareti FI. (eds). 33-41 Platelets and Thrombosis. Acad Press; London: 1977
• 23 Seaman GVF, Vassar PS. Changes in electrokinetic properties of platelets during their aggregation. Arch Biochem Biophys 1966; 117: 10-17
• 24 Hampton JR, Mitchell JRA. Modification of the electrokinetic response of blood platelets to aggregating agents. Nature 1969; 210: 1000-1003
• 25 Gröttum KA. Platelet surface charge and aggregation. Effects of polyelectrolytes. Thrombos Diathes Haemorrh 1969; 21: 450-462
• 26 Shimizu M, Iwaguchi T, Kikutani N, Motomiya T, Yamazaki H. A new method for measuring cell electrophoretic mobility. Proc Japan Acad 1979; 55: 418-423
• 27 Tanford C. Physical Chemistry of Macromolecules. In: “Transport Processes, Viscosity”. Chapter 6 John Wiley and Sons Inc; New York: 1961
• 28 Yamazaki H, Motomiya T, Watanabe C, Miyagawa N, Yahara Y, Okawa Y, Onozawa Y. Consumption of larger platelets with decrease in adenine nucleotide content in thrombosis, disseminated intravascular coagulation, and post-operative state. Thromb Res 1980; 18: 77-88
• 29 Karpatkin S. Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest 1969; 48: 1073-1082
• 30 Karpatkin S. Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 1978; 51: 307-316
• 31 Yamazaki H, Motomiya T, Sano T, Miyagawa N, Onozawa Y, Mashimo N, Matsubara O. Role of platelets in thrombogenesis. Asian Medical J 1980; 23: 156-204
• 32 Jerushalmy Z, Kohn A, De Vries A. Interaction of myxoviruses with human erythrocytes and blood platelets in vitro. Proc Soc Exp Biol Med 1961; 106: 462-466
• 33 Madoff MA, Ebbe S, Baldini M. Sialic add of human blood platelets. J Clin Invest 1964; 43: 870-877
• 34 Peerschke EI, Zucker MB. Shape change and the percentage of sialic add removed by neuraminidase from human platelets. Proc Soc Exp Biol Med 1978; 159: 54-56
• 35 Mustard JF, Packham MA. Factors influencing platelet function: adhesion, release and aggregation. Pharmacol Rev 1970; 22: 97-187
• 36 Mustard JF, Perry DW, Kinlough-Rathbone RL, Packham MA. Factors responsible for ADP-induced release of human platelets. Am J Physiol 1975; 223: 1757-1765
• 37 Charo IF, Feinman RD, Detwiler TC. Interrelations of platelet aggregation and secretion. J Clin Invest 1977; 60: 866-873
• 38 Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets; I. Acetylation of particulate fraction. J Clin Invest 1975; 56: 624-632